Company Presentation from ONO Announcing the 1st Ono Golden Ticket Event

MBC BioLabs & Ono Pharmaceutical Co., Ltd. Present the 2021 Golden Ticket Program

Please join us for a virtual seminar with Ono Pharmaceutical Co., Ltd. (ONO) and Ono Venture Investment, Inc. (OVI), its corporate venture capital arm to learn about innovation at the company, including ONO’s R&D, therapeutic and platform technology focus areas, science-led investment strategy and collaborative partnering approach – launching the call for Golden Ticket Competition entries to help accelerate innovative life science start-ups into real business that can bring value to patients. 

Register for Event: March 30, 2021, 4:00pm-5:00pm PST – Online Event





Introducing Our Presenters:

Toichi Takino (Executive Officer and Executive Director of Discovery & Research)

Kohki Tsukamoto (Associate Director, Oncology)

Yuichiro Matsushita (Associate Director, Neurology)

Daisuke Wakamatsu (Associate Director, Specialty)

Kosuke Tani (Associate Director, Immunology)

Hiroshi Yamamoto (President & CEO Ono Venture Investments, Inc.)

Tomotaka Okino (Investment Director Ono Venture Investments)

Facilitation by Robert Blazej (Director, MBC BioLabs and Partner, Mission Bay Capital)

About MBC BioLabs

Slide Schedule a Tour to Learn
How MBC BioLabs Can Help
Your Company Succeed.
Learn More About MBC BioLabs

Rent a Bench. Change the World.

We’ve Helped 203 Companies Raise $4.75B In Funding.

Talk about enabling awesome.

MBC BioLabs has helped 203 companies raise an average of $24.2M, for a total of $4.75B raised! When we say we enable awesome, we mean it. MBC BioLabs gives life science innovators and entrepreneurs the facilities and equipment they need to be running experiments from day 1. Seriously. We even have a tradition of doing a champagne toast for every company that runs an experiment on its first day.

MBC BioLabs frees startups from the Catch 22 of needing funding to get data, and needing data to get funding by providing the space, the equipment, and the community. Click below to tour one of our labs!

About Ono Pharmaceutical Co., Ltd.

Ono Pharmaceutical Co., Ltd., headquartered in Osaka, is an R&D-oriented pharmaceutical company committed to creating innovative medicines in specific areas. Ono focuses its research on the oncology, immunology, neurology and specialty research with high medical needs as priority areas for discovery and development of innovative medicines. For further information, please visit the company’s website at https://www.ono-pharma.com/.

Learn More About Ono